Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 185

1.

Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.

Kamran SC, Howard SA, Shinagare AB, Krajewski KM, Jagannathan JP, Hornick JL, Ramaiya NH.

Eur J Surg Oncol. 2013 Jan;39(1):46-52. doi: 10.1016/j.ejso.2012.09.001. Epub 2012 Oct 18.

PMID:
23084090
[PubMed - indexed for MEDLINE]
2.

Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors.

LaFemina J, Qin LX, Moraco NH, Antonescu CR, Fields RC, Crago AM, Brennan MF, Singer S.

Ann Surg Oncol. 2013 Jan;20(1):66-72. doi: 10.1245/s10434-012-2573-2. Epub 2012 Aug 10.

PMID:
22878618
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1.

Dunn GP, Spiliopoulos K, Plotkin SR, Hornicek FJ, Harmon DC, Delaney TF, Williams Z.

J Neurosurg. 2013 Jan;118(1):142-8. doi: 10.3171/2012.9.JNS101610. Epub 2012 Oct 26.

PMID:
23101443
[PubMed - indexed for MEDLINE]
4.

Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.

Ziadi A, Saliba I.

Auris Nasus Larynx. 2010 Oct;37(5):539-45. doi: 10.1016/j.anl.2010.02.009. Review.

PMID:
20399579
[PubMed - indexed for MEDLINE]
5.

[A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].

Malerba M, Garofalo A.

Tumori. 2003 Jul-Aug;89(4 Suppl):246-50. Italian.

PMID:
12903608
[PubMed - indexed for MEDLINE]
6.

Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome.

Zou C, Smith KD, Liu J, Lahat G, Myers S, Wang WL, Zhang W, McCutcheon IE, Slopis JM, Lazar AJ, Pollock RE, Lev D.

Ann Surg. 2009 Jun;249(6):1014-22. doi: 10.1097/SLA.0b013e3181a77e9a.

PMID:
19474676
[PubMed - indexed for MEDLINE]
7.

Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors.

Hagel C, Zils U, Peiper M, Kluwe L, Gotthard S, Friedrich RE, Zurakowski D, von Deimling A, Mautner VF.

J Neurooncol. 2007 Apr;82(2):187-92. Epub 2006 Nov 17.

PMID:
17111191
[PubMed - indexed for MEDLINE]
8.

Clinical signs of neurofibromatosis impact on the outcome of malignant peripheral nerve sheath tumors.

Lamm W, Schur S, Köstler WJ, Funovics P, Windhager R, Amann G, Panotopoulos J, Pokrajac B, Brodowicz T.

Oncology. 2014;86(2):122-6. doi: 10.1159/000357137. Epub 2014 Jan 28.

PMID:
24480823
[PubMed - indexed for MEDLINE]
9.

Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience.

Stucky CC, Johnson KN, Gray RJ, Pockaj BA, Ocal IT, Rose PS, Wasif N.

Ann Surg Oncol. 2012 Mar;19(3):878-85. doi: 10.1245/s10434-011-1978-7. Epub 2011 Aug 23.

PMID:
21861229
[PubMed - indexed for MEDLINE]
10.

Malignant peripheral nerve sheath tumor: a study of 21 cases.

Chang SM, Ho WL.

Zhonghua Yi Xue Za Zhi (Taipei). 1994 Aug;54(2):122-30.

PMID:
7954046
[PubMed - indexed for MEDLINE]
11.

Malignant peripheral nerve sheath tumor: analysis of treatment outcome.

Wong WW, Hirose T, Scheithauer BW, Schild SE, Gunderson LL.

Int J Radiat Oncol Biol Phys. 1998 Sep 1;42(2):351-60.

PMID:
9788415
[PubMed - indexed for MEDLINE]
12.

Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.

Fang Y, Elahi A, Denley RC, Rao PH, Brennan MF, Jhanwar SC.

Anticancer Res. 2009 Apr;29(4):1255-62.

PMID:
19414372
[PubMed - indexed for MEDLINE]
Free Article
13.

Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.

Endo M, Yamamoto H, Setsu N, Kohashi K, Takahashi Y, Ishii T, Iida K, Matsumoto Y, Hakozaki M, Aoki M, Iwasaki H, Dobashi Y, Nishiyama K, Iwamoto Y, Oda Y.

Clin Cancer Res. 2013 Jan 15;19(2):450-61. doi: 10.1158/1078-0432.CCR-12-1067. Epub 2012 Dec 3.

PMID:
23209032
[PubMed - indexed for MEDLINE]
Free Article
14.

Malignant triton tumors--complete surgical resection and adjuvant radiotherapy associated with improved survival.

McConnell YJ, Giacomantonio CA.

J Surg Oncol. 2012 Jul 1;106(1):51-6. doi: 10.1002/jso.23042. Epub 2012 Jan 17.

PMID:
22253011
[PubMed - indexed for MEDLINE]
15.

Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.

Leroy K, Dumas V, Martin-Garcia N, Falzone MC, Voisin MC, Wechsler J, Revuz J, Créange A, Levy E, Lantieri L, Zeller J, Wolkenstein P.

Arch Dermatol. 2001 Jul;137(7):908-13.

PMID:
11453810
[PubMed - indexed for MEDLINE]
16.

Malignant peripheral nerve sheath tumors (MPNST) in NF1-affected children.

Friedrich RE, Hartmann M, Mautner VF.

Anticancer Res. 2007 Jul-Aug;27(4A):1957-60.

PMID:
17649804
[PubMed - indexed for MEDLINE]
Free Article
17.

Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1.

Kolberg M, Høland M, Agesen TH, Brekke HR, Liestøl K, Hall KS, Mertens F, Picci P, Smeland S, Lothe RA.

Neuro Oncol. 2013 Feb;15(2):135-47. doi: 10.1093/neuonc/nos287. Epub 2012 Nov 15. Review.

PMID:
23161774
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

[18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation.

Tsai LL, Drubach L, Fahey F, Irons M, Voss S, Ullrich NJ.

J Neurooncol. 2012 Jul;108(3):469-75. doi: 10.1007/s11060-012-0840-5. Epub 2012 Mar 11.

PMID:
22407214
[PubMed - indexed for MEDLINE]
19.

Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis.

Doorn PF, Molenaar WM, Buter J, Hoekstra HJ.

Eur J Surg Oncol. 1995 Feb;21(1):78-82.

PMID:
7851559
[PubMed - indexed for MEDLINE]
20.

Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group.

Carli M, Ferrari A, Mattke A, Zanetti I, Casanova M, Bisogno G, Cecchetto G, Alaggio R, De Sio L, Koscielniak E, Sotti G, Treuner J.

J Clin Oncol. 2005 Nov 20;23(33):8422-30. Erratum in: J Clin Oncol. 2006 Feb 1;24(4):724. Koscielniak, Eura [corrected to Koscielniak, Ewa].

PMID:
16293873
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk